Compositions and Methods for Modulating Inflammation Using Fluoroquinolones
OwnerJinzhong Zhang, Keith Wayne Wardinventors
Life of this patent
Estimating the term…
Abstract
Compositions for modulating an inflammation comprise a fluoroquinolone having one of Formulae I-VIII. Methods for modulating an inflammation comprise administering such compositions to a subject in need thereof. The compositions and methods are suitable for modulating an ocular or ophthalmic inflammation, including uveitis, vernal keratoconjunctivitis, or inflammation associated with contact lens-associated corneal infiltrates.
Claims30
A method for modulating an inflammation in a subject, the method comprising administering to the subject a composition comprising an effective amount of a fluoroquinolone having Formula I, II, III, IV, V, VI, VII, or VIII, or a salt thereof
- wherein R1 is selected from the group consisting of hydrogen, unsubstituted lower alkyl groups, substituted lower alkyl groups, cycloalkyl groups, unsubstituted C5-C24 aryl groups, substituted C5-C24 aryl groups, unsubstituted C5-C24 heteroaryl groups, substituted C5-C24 heteroaryl groups, and groups that can be hydrolyzed in living bodies;
- R2 is selected from the group consisting of hydrogen, unsubstituted amino group, and amino groups substituted with one or two lower alkyl groups;
- R3 is selected from the group consisting of hydrogen, unsubstituted lower alkyl groups, substituted lower alkyl groups, cycloalkyl groups, unsubstituted lower alkoxy groups, substituted lower alkoxy groups, unsubstituted C5-C24 aryl groups, substituted C5-C24 aryl groups, unsubstituted C5-C24 heteroaryl groups, substituted C5-C24 heteroaryl groups, unsubstituted C5-C24 aryloxy groups, substituted C5-C24 aryloxy groups, unsubstituted C5-C24 heteroaryloxy groups, substituted C5-C24 heteroaryloxy groups, and groups that can be hydrolyzed in living bodies;
- X is selected from the group consisting of halogen atoms;
- Y is selected from the group consisting of CH2, O, S, SO, SO2, and NR4, wherein R4 is selected from the group consisting of hydrogen, unsubstituted lower alkyl groups, substituted lower alkyl groups, and cycloalkyl groups;
- and
- Z is selected from the group consisting of oxygen and two hydrogen atoms.
A method for modulating an inflammation in a subject, the method comprising administering to the subject a composition comprising an effective amount of a fluoroquinolone having Formula IV or a salt thereof
A method for treating, controlling, reducing, or ameliorating an ocular or ophthalmic infection and an inflammatory sequela thereof in a subject, the method comprising administering to the subject a composition comprising an effective amount of a fluoroquinolone having Formula IV or a salt thereof
A method for modulating an inflammation in a subject, the method comprising administering to the subject a composition comprising an effective amount of a fluoroquinolone having Formula VI or a salt thereof
A method for treating, controlling, reducing, or ameliorating an ocular or ophthalmic infection and an inflammatory sequela thereof in a subject, the method comprising administering to the subject a composition comprising an effective amount of a fluoroquinolone having Formula VI or a salt thereof
Use of a fluoroquinolone having Formula I, II, III, IV, V, VI, VII, or VIII for a preparation of a medicament for modulating an inflammation in a subject.
A pharmaceutical composition comprising a fluoroquinolone having Formula I, II, III, IV, V, VI, VII, or VIII, wherein said fluoroquinolone is present in an amount effective to modulate an inflammation.
Dependencies are inferred from the claim text.